Ubiquinone (coenzyme Q) functions in both mitochondria and plasma membrane electron transport, and a growing body of evidence suggests that the ubiquinol/ubiquinone redox couple also functions as a potent, lipid soluble antioxidant system. In this latter capacity, ubiquinol (coenzyme QH2) may scavenge lipid peroxyl radicals, a class of oxidative products that represents a major cause of damage to cellular membranes, proteins, and DNA. There is a growing body of evidence that oxidative damage in mammalian cells is one of the major causes of cancer and age-related degenerative diseases, and that oxidative modifications of low density lipoprotein lipids may plan an important role in the initiation of coronary artery disease. Ubiquinone/ubiquinol is the only lipid soluble antioxidant that can be synthesized by mammalian cells. Although dietary supplementation with ubiquinone increases ubiquinol levels in the liver and lipoproteins of animals, it has little impact on the levels of ubiquinone in other tissues. Thus, it is de novo synthesis that sets the body level of ubiquinone and ubiquinol. It is surprising that the enzymology of ubiquinone biosynthesis is not understood, and the eukaryotic gene enzyme relationships have not been established. The goals of the proposed research include the elucidation of the gene enzyme relationships of ubiquinone biosynthesis, and the characterization of the polypeptide components responsible for the production of ubiquinone. The experimental system takes advantage of eight complementation groups of ubiquinone deficient (coq) mutants in the yeast Saccharomyces cerevisiae. The availability of the yeast coq mutants provides the basis for the isolation and characterization of the COQ genes and their products in both yeast and mammals. Synthetic analogs of ubiquinone intermediates provide reagents that serve both as standards in the isolation and characterization of ubiquinone intermediates, and as substrates for in vitro assays of enzyme activities. The experimental approach employs the combination of chemistry, genetics, and biochemistry to delineate the eukaryotic biosynthetic steps responsible for the production of ubiquinone, as well as to investigate the function of ubiquinone/ubiquinol as an antioxidant.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM045952-08
Application #
6018836
Study Section
Biochemistry Study Section (BIO)
Project Start
1991-04-01
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
8
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
He, Cuiwen H; Xie, Letian X; Allan, Christopher M et al. (2014) Coenzyme Q supplementation or over-expression of the yeast Coq8 putative kinase stabilizes multi-subunit Coq polypeptide complexes in yeast coq null mutants. Biochim Biophys Acta 1841:630-44
Gasser, David L; Winkler, Cheryl A; Peng, Min et al. (2013) Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q10. Am J Physiol Renal Physiol 305:F1228-38
Allan, Christopher M; Hill, Shauna; Morvaridi, Susan et al. (2013) A conserved START domain coenzyme Q-binding polypeptide is required for efficient Q biosynthesis, respiratory electron transport, and antioxidant function in Saccharomyces cerevisiae. Biochim Biophys Acta 1831:776-791
Hill, Shauna; Lamberson, Connor R; Xu, Libin et al. (2012) Small amounts of isotope-reinforced polyunsaturated fatty acids suppress lipid autoxidation. Free Radic Biol Med 53:893-906
Xie, Letian X; Ozeir, Mohammad; Tang, Jeniffer Y et al. (2012) Overexpression of the Coq8 kinase in Saccharomyces cerevisiae coq null mutants allows for accumulation of diagnostic intermediates of the coenzyme Q6 biosynthetic pathway. J Biol Chem 287:23571-81
Rahman, Shamima; Clarke, Catherine F; Hirano, Michio (2012) 176th ENMC International Workshop: diagnosis and treatment of coenzyme Q?? deficiency. Neuromuscul Disord 22:76-86
Falk, Marni J; Polyak, Erzsebet; Zhang, Zhe et al. (2011) Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice. EMBO Mol Med 3:410-27
Clarke, Catherine F (2011) Coq6 hydroxylase: unmasked and bypassed. Chem Biol 18:1069-70
Heeringa, Saskia F; Chernin, Gil; Chaki, Moumita et al. (2011) COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest 121:2013-24
Xie, Letian X; Hsieh, Edward J; Watanabe, Shota et al. (2011) Expression of the human atypical kinase ADCK3 rescues coenzyme Q biosynthesis and phosphorylation of Coq polypeptides in yeast coq8 mutants. Biochim Biophys Acta 1811:348-60

Showing the most recent 10 out of 24 publications